Clinical Trial Update: Safety and Efficacy of Modified Folfirinox Versus Gemcis in Bile Duct Tumours [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 trial comparing Modified Folfirinox to Gemcitabine+Cisplatin in bile duct cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bile Duct Cancer

Drugs mentioned

• Modified FOLFIRINOX (modified FOLFIRINOX)
• gemcitabine/cisplatin

Snippet

Sponsor: Centre Hospitalier Universitaire de Saint Etienne | Conditions: Bile Duct Cancer | Phase 2, Phase 3 | Status: COMPLETED